tetano
Editor, Senior Moderator
Med Mal Infect. 2018 Nov 13. pii: S0399-077X(17)30956-3. doi: 10.1016/j.medmal.2018.10.008. [Epub ahead of print]
[h=1]Analysis of delays in the prescription of oseltamivir in hospitals and potential for improvement.[/h] Martinot M[SUP]1[/SUP], Gronnwald A[SUP]2[/SUP], Gerber V[SUP]2[/SUP], Greigert V[SUP]2[/SUP], Rosolen B[SUP]2[/SUP], De Briel D[SUP]3[/SUP], Mohseni Zadeh M[SUP]2[/SUP], Thibaud E[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] Patients hospitalized for influenza should receive early treatment with a neuraminidase inhibitor.
[h=4]PATIENTS AND METHODS:[/h] We conducted a retrospective study of the prescription of oseltamivir during the 2016-2017 influenza epidemic among patients hospitalized for influenza confirmed by RT-PCR in the infectious disease department.
[h=4]RESULTS:[/h] Treatment with oseltamivir was initiated as recommended in 96% of hospitalized patients presenting with influenza. However, a delay in prescription was observed with only 18% of prescriptions made on the first day. The prescriptions were exclusively initiated in the infectious disease department.
[h=4]CONCLUSION:[/h] To improve the early prescription of oseltamivir during the influenza season, two recommendations are essential: oseltamivir availability in the emergency department pharmacy, awareness of physicians of the need to prescribe to any patient hospitalized for a lower respiratory tract infection treatment with a neuraminidase inhibitor upon admission to the emergency department.
Copyright ? 2018 Elsevier Masson SAS. All rights reserved.
[h=4]KEYWORDS:[/h] Grippe; Influenza; Oseltamivir
PMID: 30446349 DOI: 10.1016/j.medmal.2018.10.008
[h=1]Analysis of delays in the prescription of oseltamivir in hospitals and potential for improvement.[/h] Martinot M[SUP]1[/SUP], Gronnwald A[SUP]2[/SUP], Gerber V[SUP]2[/SUP], Greigert V[SUP]2[/SUP], Rosolen B[SUP]2[/SUP], De Briel D[SUP]3[/SUP], Mohseni Zadeh M[SUP]2[/SUP], Thibaud E[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] Patients hospitalized for influenza should receive early treatment with a neuraminidase inhibitor.
[h=4]PATIENTS AND METHODS:[/h] We conducted a retrospective study of the prescription of oseltamivir during the 2016-2017 influenza epidemic among patients hospitalized for influenza confirmed by RT-PCR in the infectious disease department.
[h=4]RESULTS:[/h] Treatment with oseltamivir was initiated as recommended in 96% of hospitalized patients presenting with influenza. However, a delay in prescription was observed with only 18% of prescriptions made on the first day. The prescriptions were exclusively initiated in the infectious disease department.
[h=4]CONCLUSION:[/h] To improve the early prescription of oseltamivir during the influenza season, two recommendations are essential: oseltamivir availability in the emergency department pharmacy, awareness of physicians of the need to prescribe to any patient hospitalized for a lower respiratory tract infection treatment with a neuraminidase inhibitor upon admission to the emergency department.
Copyright ? 2018 Elsevier Masson SAS. All rights reserved.
[h=4]KEYWORDS:[/h] Grippe; Influenza; Oseltamivir
PMID: 30446349 DOI: 10.1016/j.medmal.2018.10.008